Merrion Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Merrion Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$380K	Hold	2,000	–	–	0.18%	88
2026 Q1	$338K	Hold	2,000	–	–	0.18%	89
2025 Q4	$338K	Buy	+2,000	New	+$325K	0.18%	91
2024 Q4	–	Sell	-2,000	Closed	-$291K	–	105
2024 Q3	$291K	Hold	2,000	–	–	0.19%	86
2024 Q2	$275K	Hold	2,000	–	–	0.19%	83
2024 Q1	$274K	Sell	2,000 -650	-25%	-$88.8K	0.2%	87
2023 Q4	$360K	Sell	2,650 -2,000	-43%	-$244K	0.28%	66
2023 Q3	$569K	Hold	4,650	–	–	0.49%	42
2023 Q2	$590K	Sell	4,650 -50	-1%	-$6.5K	0.5%	41
2023 Q1	$607K	Sell	4,700 -100	-2%	-$13.1K	0.58%	34
2022 Q4	$630K	Hold	4,800	–	–	0.59%	36
2022 Q3	$561K	Hold	4,800	–	–	0.55%	41
2022 Q2	$565K	Sell	4,800 -1,000	-17%	-$119K	0.55%	42
2022 Q1	$755K	Hold	5,800	–	–	0.55%	36
2021 Q4	$885K	Hold	5,800	–	–	0.65%	32
2021 Q3	$937K	Hold	5,800	–	–	0.71%	29
2021 Q2	$949K	Hold	5,800	–	–	0.72%	32
2021 Q1	$873K	Hold	5,800	–	–	0.73%	31
2020 Q4	$879K	Buy	+5,800	New	+$829K	0.74%	31

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Merrion Investment Management's IBB Position: Q2 2026 in Review

Merrion Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,000 shares worth $380K. The position accounts for 0.18% of the portfolio, ranked #88.

Merrion Investment Management first reported a position in IBB in Q4 2020 and has held it in 19 quarters since. The position peaked at $949K in Q2 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Merrion Investment Management held 2,000 shares of iShares Biotechnology ETF worth $380K as of Q2 2026.
Merrion Investment Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.18% of Merrion Investment Management's portfolio in Q2 2026, its #88 holding.
Merrion Investment Management first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 19 quarters since.
Merrion Investment Management's iShares Biotechnology ETF position peaked at $949K in Q2 2021.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Merrion Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.